- Home
- WST vs LII Comparison
WST vs LII Comparison
Compare WST & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- LII
- Stock Information
- Founded
- WST 1923
- LII 1895
- Country
- WST United States
- LII United States
- Employees
- WST N/A
- LII N/A
- Industry
- WST Medical/Dental Instruments
- LII Industrial Machinery/Components
- Sector
- WST Health Care
- LII Industrials
- Exchange
- WST Nasdaq
- LII Nasdaq
- Market Cap
- WST 23.2B
- LII 21.7B
- IPO Year
- WST N/A
- LII 1999
- Fundamental
- Price
- WST $332.02
- LII $628.82
- Analyst Decision
- WST Strong Buy
- LII Buy
- Analyst Count
- WST 5
- LII 13
- Target Price
- WST $437.75
- LII $583.50
- AVG Volume (30 Days)
- WST 494.1K
- LII 640.9K
- Earning Date
- WST 02-13-2025
- LII 01-29-2025
- Dividend Yield
- WST 0.25%
- LII 0.73%
- EPS Growth
- WST N/A
- LII 38.78
- EPS
- WST 6.74
- LII 21.04
- Revenue
- WST $2,876,400,000.00
- LII $5,151,100,000.00
- Revenue This Year
- WST N/A
- LII $5.80
- Revenue Next Year
- WST $6.08
- LII $7.04
- P/E Ratio
- WST $49.37
- LII $29.99
- Revenue Growth
- WST N/A
- LII 4.68
- 52 Week Low
- WST $265.00
- LII $412.09
- 52 Week High
- WST $413.70
- LII $682.50
- Technical
- Relative Strength Index (RSI)
- WST 58.00
- LII 45.50
- Support Level
- WST $325.33
- LII $612.51
- Resistance Level
- WST $335.53
- LII $669.50
- Average True Range (ATR)
- WST 7.96
- LII 19.30
- MACD
- WST 0.32
- LII -5.42
- Stochastic Oscillator
- WST 78.28
- LII 28.33
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2023, residential HVAC was 68% of sales and commercial HVAC and Heatcraft refrigeration was 32% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.